Nateglinide antidiabetic drugs  

Fastic - A-4166 - A 4166 - Novartis brand of nateglinide - Starlix - Starsis - DJN 608 - AY-4166 - AY 4166 - IPCCPA - senaglinide - nate-glinide - nateglinide      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultDiabetes normoglycemia

diabetes type 2  

NAVIGATOR nateglinide, 2010    NCTnateglinideplaceboLow risk of bias negative 6%
Marre, 2002     nateglinideplaceboLow risk of bias -
Horton, 2000   nateglinideplaceboLow risk of bias -
Hanefeld, 1990   nateglinideplaceboLow risk of bias -
Saloranta, 2002   nateglinideplaceboLow risk of bias -
Mari, 2005   nateglinideplacebo -
Moses, 2001   nateglinideplaceboLow risk of bias -
Goldberg, 1998   repaglinideplaceboLow risk of bias -
Jovanovic, 2000   repaglinideplaceboLow risk of bias -
Bech, 2003   repaglinideplaceboLow risk of bias -
Li, 2009   nategliniderepaglinide -
Li, 2007   nategliniderepaglinide -
Ristic, 2006       nateglinidegliclazide (add on MET)Low risk of bias -

impaired fasting glucose  

NAVIGATOR nateglinide, 2010    NCTnateglinideplaceboLow risk of bias negative 6%